CELLECTRA® 2000

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 ExposureNCT04642638Inovio PharmaceuticalsPhase 2, Phase 3Terminated2022-09-13Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.